Tapentadol IR (CG5503)

DRUG2 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions

ArthritisArthroplastyJoint DiseasesOsteoarthritis

Phase 3

A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety

TerminatedNCT00364533

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Arthroplasty

Start: 2006-10-31End: 2007-12-31Updated: 2014-04-21

A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease

CompletedNCT00784277

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Arthritis, Joint Diseases, Osteoarthritis

Start: 2008-10-31End: 2009-07-31Updated: 2012-02-13